Clinical Trials · NCT02064582
Enzalutamide and Hormone Therapy Before, During, and After Radiation for High Risk Localized Prostate Cancer
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- University of Texas Southwestern Medical Center
- Enrollment
- 7
- Start date
- May 2014
- Locations
- 1 site, United States
- Primary endpoint
- Safety, as Measured by the Number of Patients With at Least One Adverse Event as Assess by NCI Common Terminology Criteria for Adverse Events (CTCAE) vs. 40 When Combining Enzalutamide With a GnRH and External Beam Radiation